Chief, Section of Hematology/Oncology
The University of Chicago: Biological Sciences Division: Department of Medicine
The Department of Medicine at the University of Chicago invites applications for the position of Chief, Section of Hematology/Oncology. The appointee will be an accomplished program builder with a strong background in clinical oncology and/or hematology, an experienced leader to support and enhance the Section's clinical, research and educational eminence, and have a national reputation in scholarship with independent grant and/or active clinical research funding. Academic rank (Associate Professor or Professor), tenure, and compensation (including a generous package of fringe benefits) are dependent upon qualifications.
The Section of Hematology/Oncology has a long and distinguished history of excellence in research-based clinical care, discovery and education. Ranked among the finest cancer programs in the country, the Section comprises more than 40 nationally and internationally known full-time faculty with expertise in all major types of hematologic malignancies, solid tumors, blood disorders, and experimental therapies, with special emphasis on translational and clinical research and immunotherapies. The strength and success of the Section reflects the quality and dedication of its faculty, trainees and staff, and is enhanced by the rich environment and at the University of Chicago.
The Chief will provide visionary leadership, support and mentoring of faculty for the growth of an outstanding clinical and scholarly Section.
Clinical: Oversight of the Section’s five inpatient services at the Center for Care and Discovery (CCD) and outpatient operations at the Duchossois Center for Advanced Medicine (DCAM) that comprise 50,000 visits per year. In addition, work with University and Hospital leadership to strategically grow the integrated network with multiple sites offering clinical care and clinical trials to the community-at-large.
Research: Provide guidance and support to expand the Section’s portfolio of grants, contracts and clinical trials from bench to bedside. The Section remains a national leader in the development of new insights in the treatment of cancer and blood disorders with an active and robust research program represented by direct faculty awards and/or participation (via subcontracts) in 20 federally-funded grants, approximately 60 non-federally funded research projects and over 380 industry-sponsored clinical trials (approximately $36M annual funding).
Education: Support the Section’s ACGME-accredited three-year fellowship program that totals 21 fellows and has been supported by an NIH training grant for 17 years. Additional post-fellowship education comprises 2-4 fellows per year and is supported in part by an additional NIH training grant focused on clinical pharmacology.
Please contact our Korn Ferry consulting team c/o firstname.lastname@example.org or (215) 861-2559 for an expanded position specification, inquiries and nominations.
Prior to the start of employment, qualified applicants must: 1) have a medical doctorate or equivalent, 2) hold or be eligible for medical licensure in the State of Illinois, and 3) be board certified in Hematology and/or Oncology.
To be considered, those interested must apply through The University of Chicago’s Academic Recruitment job board, which uses Interfolio to accept applications: http://apply.interfolio.com/72865. Applicants must upload: a CV including bibliography and cover letter. Review of applications will continue until the position is filled.